Increased Activity of Catalase in Tumor Cells Overexpressing IGFBP-2

Hormone and Metabolic Research

Volumn 35, Issue 11-12, 2003, Pages 816-821

  Hoeflich, A ^a   Fettscher, O ^a   Preta, C ^b   Lahm, H ^a   Kolb, H J ^c   Wolf, E ^a   Weber, M M ^d  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF FERRARA   (Italy)

^c Institut fur Klinische Chemie   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Adaption; Glutathione S transferase; Oxidative stress; Peroxidase; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; SOMATOMEDIN BINDING PROTEIN 2; SUPEROXIDE DISMUTASE;

ADRENAL CORTEX CELL; ADRENAL CORTEX TUMOR; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL DENSITY; CELL STRAIN CACO 2; CELL VIABILITY; COLON TUMOR; ENZYME ACTIVITY; ENZYME REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS; TUMOR CELL LINE; UPREGULATION;

ADRENAL CORTEX NEOPLASMS; ANIMALS; CATALASE; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; KIDNEY; KINETICS; MICE; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 0346095211     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814163     Document Type: Article

References (29)

1. Hoeflich A, Reisinger R, Lahm H, Kiess W, Blum WF, Kolb HJ, Weber MM, Wolf E. Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter? Cancer Res 2001; 61: 8601-8610
2. Wolf E, Lahm H, Wu M, Wanke R, Hoeflich A. Effects of IGFBP-2 overexpression in vitro and in vivo. Pediatr Nephrol 2000; 14: 572-578
3. Cazals V, Mouhieddine B, Maitre B, Le Bouc Y, Chadelat K, Brody JS, Clement A. Insulin-like growth factors, their binding proteins, and transforming growth factor-beta 1 in oxidant-arrested lung alveolar epithelial cells. J Biol Chem 1994; 269: 14 111-14 117
4. Besnard V, Corroyer S, Trugnan G, Chadelat K, Nabeyrat E, Cazals V, Clement A. Distinct patterns of insulin-like growth factor binding protein (IGFBP)-2 and IGFBP-3 expression in oxidant exposed lung epithelial cells. Biochim Biophys Acta 2001; 1538: 47-58
5. Cazals V, Nabeyrat E, Corroyer S, de Keyzer Y, Clement A. Role for NF-kappa B in mediating the effects of hyperoxia on IGF-binding protein 2 promoter activity in lung alveolar epithelial cells. Biochim Biophys Acta 1999; 1448: 349-362
6. Oberley TD, Oberley LW. Antioxidant enzyme levels in cancer. Histol Histopathol 1997; 12: 525-535
7. van Rossen ME, Sluiter W, Bonthuis F, Jeekel H, Marquet RL, van Eijck CH. Scavenging of reactive oxygen species leads to diminished peritoneal tumor recurrence. Cancer Res 2000; 60: 5625-5629
8. Lu YP, Lou YR, Yen P, Newmark HL, Mirochnitchenko OI, Inouye M, Huang MT. Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase. Cancer Res 1997; 57: 1468-1474
9. Sadani GR, Nadkarni GD. Role of tissue antioxidant defence in thyroid cancers. Cancer Lett 1996; 109: 231-235
10. Heck DE, Vetrano AM, Mariano TM, Laskin JD. UVB light stimulates production of reactive oxygen species: unexpected role for catalase. J Biol Chem 2003; 278: 22432-22436
11. Hoeflich A, Fettscher O, Lahm H, Blum WF, Kolb HJ, Engelhardt D, Wolf E, Weber MM. Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells. Cancer Res 2000; 60: 834-838
12. Höflich A, Lahm H, Blum W, Kolb H, Wolf E. Insulin-like growth factor-binding protein-2 inhibits proliferation of human embryonic kidney fibroblasts and of IGF-responsive colon carcinoma cell lines. FEBS Lett 1998; 434: 329-334
13. Borenfreund E, Puerner JA. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985; 24: 119-124
14. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126
15. Madesh M, Balasubramanian KA. Microtiter plate assay for superoxide dismutase using MTT reduction by superoxide. Indian J Biochem Biophys 1998; 35: 184-188
16. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-7139
17. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-478
18. Hoeflich A, Nedbal S, Blum WF, Erhard M, Lahm H, Brem G, Kolb H, Wanke R, Wolf E. Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2. Endocrinology 2001; 142: 1889-1898
19. Sander CS, Hamm F, Elsner P, Thiele JJ. Oxidative stress in malignant melanoma and non-melanoma skin cancer. Br J Dermatol 2003; 148: 913-922
20. Cullen JJ, Mitros FA, Oberley LW. Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer. Pancreas 2003; 26: 23-27
21. Weydert C, Roling B, Liu J, Hinkhouse MM, Ritchie JM, Oberley LW, Cullen JJ. Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase. Mol Cancer Ther 2003; 2: 361-369
22. Bilodeau JF, Patenaude A, Piedboeuf B, Carrier C, Petrov P, Faure R, Mirault ME. Glutathione peroxidase-1 expression enhances recovery of human breast carcinoma cells from hyperoxic cell cycle arrest. Free Radic Biol Med 2002; 33: 1279-1289
23. Brown-Borg HM, Rakoczy SG, Romanick MA, Kennedy MA. Effects of growth hormone and insulin-like growth factor-1 on hepatocyte antioxidative enzymes. Exp Biol Med (Maywood) 2002; 227: 94-104
24. Xie C, Lovell MA, Xiong S, Kindy MS, Guo J, Xie J, Amaranth V, Montine TJ, Markesbery WR. Expression of glutathione-S-transferase isozyme in the SY5Y neuroblastoma cell line increases resistance to oxidative stress. Free Radic Biol Med 2001; 31: 73-81
25. Bai J, Cederbaum AI. Catalase protects HepG2 cells from apoptosis induced by DNA-damaging agents by accelerating the degradation of p53. J Biol Chem 2003; 278: 4660-4667
26. Tome ME, Baker AF, Powis G, Payne CM, Briehl MM. Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth. Cancer Res 2001; 61: 2766-2773
27. Kim HS, Lee TB, Choi CH. Down-regulation of catalase gene expression in the doxorubicin-resistant AML subline AML-2/DX100. Biochem Biophys Res Commun 2001; 281: 109-114
28. Bubendorf L, Kolmer M, Kononen J, Koivisto P, Mousses S, Chen Y, Mahlamaki E, Schraml P, Moch H, Willi N, Elkahloun AG, Pretlow TG, Gasser TC, Mihatsch MJ, Sauter G, Kallioniemi OP. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst 1999; 91: 1758-1764
29. Moore MG, Wetterau LA, Francis MJ, Peehl DM, Cohen P. Novel stimulatory role for insulin-like growth factor binding protein-2 in prostate cancer cells. Int J Cancer 2003; 105: 14-19